Gabriel Baertschi
Director/Board Member bij DKSH HOLDING AG
Profiel
Gabriel Baertschi is currently the Chairman-Executive Board & Chief Executive Officer at Grünenthal GmbH, as well as the Chairman & Chief Executive Officer at Grünenthal Pharma GmbH & Co. KG, the Chief Executive Officer at Grunenthal Italia Srl, and a Director at DKSH Holding AG and MedXCell SA. Previously, he was the President at AstraZeneca KK from 2013 to 2016, the President at AstraZeneca Thailand Ltd.
from 2009 to 2010, and the President at AstraZeneca GmbH from 2010 to 2012.
He graduated from Université de Neuchâtel.
Actieve functies van Gabriel Baertschi
| Bedrijven | Functie | Begin |
|---|---|---|
| DKSH HOLDING AG | Director/Board Member | 16-03-2023 |
Grünenthal GmbH
 Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Chief Executive Officer | 01-10-2016 |
Grünenthal Pharma GmbH & Co. KG
 Grünenthal Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Grünenthal Pharma GmbH & Co. KG engages in the development and manufacture of pharmaceutical products. It specializes in the treatment of pain and inflammation. The company is headquartered in Aachen, Germany. | Chief Executive Officer | - |
Grunenthal Italia Srl
 Grunenthal Italia Srl Pharmaceuticals: MajorHealth Technology Grunenthal Italia Srl is an Italian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Milan, Italy. The CEO of the company is Gabriel Baertschi. | Chief Executive Officer | - |
MedXCell SA
 MedXCell SA BiotechnologyHealth Technology MedXCell SA is a European cell therapy venture builder that focuses on identifying scientific breakthroughs and transforming them into clinical assets. The private company is based in Montreux, Switzerland. The Swiss company has a strong industrial mindset and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development, and funding capabilities. MedXCell scouts for promising ideas within its European academic network of partners, selects the most commercially-viable ideas, and co-develops them with academic institutions until the proof-of-principle stage. The company creates pipeline companies based on those ideas that can be funded independently and monetizes those that can be sold or out-licensed as early-stage assets. MedXCell was founded in 2016 by Laurent Zbinden, who has been the CEO since then. | Director/Board Member | - |
Eerdere bekende functies van Gabriel Baertschi
| Bedrijven | Functie | Einde |
|---|---|---|
AstraZeneca KK
 AstraZeneca KK Pharmaceuticals: MajorHealth Technology AstraZeneca KK develops, manufactures and sells prescription drugs. It also conducts medical research. The company was founded on April 11, 1975 and is headquartered in Osaka, Japan. | President | 01-01-2016 |
AstraZeneca GmbH
 AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca GmbH is a German pharmaceutical company that manufactures and sells pharmaceutical drugs. The private company is based in Wedel, Germany. The company was founded in 1999. The CEO is Hans Sijbesma. | President | 01-01-2012 |
AstraZeneca Thailand Ltd.
 AstraZeneca Thailand Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Thailand Ltd. operates as a science-led biopharmaceutical company. The private company is based in Bangkok, Thailand. | President | 01-01-2010 |
Opleiding van Gabriel Baertschi
| Université de Neuchâtel | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DKSH HOLDING AG | Distribution Services |
| Bedrijven in privébezit | 7 |
|---|---|
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Health Technology |
AstraZeneca KK
AstraZeneca KK Pharmaceuticals: MajorHealth Technology AstraZeneca KK develops, manufactures and sells prescription drugs. It also conducts medical research. The company was founded on April 11, 1975 and is headquartered in Osaka, Japan. | Health Technology |
Grünenthal Pharma GmbH & Co. KG
Grünenthal Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Grünenthal Pharma GmbH & Co. KG engages in the development and manufacture of pharmaceutical products. It specializes in the treatment of pain and inflammation. The company is headquartered in Aachen, Germany. | Health Technology |
AstraZeneca Thailand Ltd.
AstraZeneca Thailand Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Thailand Ltd. operates as a science-led biopharmaceutical company. The private company is based in Bangkok, Thailand. | Health Technology |
Grunenthal Italia Srl
Grunenthal Italia Srl Pharmaceuticals: MajorHealth Technology Grunenthal Italia Srl is an Italian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Milan, Italy. The CEO of the company is Gabriel Baertschi. | Health Technology |
MedXCell SA
MedXCell SA BiotechnologyHealth Technology MedXCell SA is a European cell therapy venture builder that focuses on identifying scientific breakthroughs and transforming them into clinical assets. The private company is based in Montreux, Switzerland. The Swiss company has a strong industrial mindset and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development, and funding capabilities. MedXCell scouts for promising ideas within its European academic network of partners, selects the most commercially-viable ideas, and co-develops them with academic institutions until the proof-of-principle stage. The company creates pipeline companies based on those ideas that can be funded independently and monetizes those that can be sold or out-licensed as early-stage assets. MedXCell was founded in 2016 by Laurent Zbinden, who has been the CEO since then. | Health Technology |
AstraZeneca GmbH
AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca GmbH is a German pharmaceutical company that manufactures and sells pharmaceutical drugs. The private company is based in Wedel, Germany. The company was founded in 1999. The CEO is Hans Sijbesma. | Health Technology |
